// App-Quantinova.ai

AB0548 (2021) : EFFECTIVENESS OF IXEKIZUMAB IN PATIENTS WITH PSORIATIC ARTHRITIS: RESULTS FROM A REAL-WORLD EUROPEAN SURVEY

Researchers

Presenter

  • W. Tillett

Principal Investigators

  • V. Navarro-Compn

  • N. Booth

  • T. Holzkaemper

  • J. Hill

  • E. Lubrano

Medical Centers

  • Royal National Hospital for Rheumatic Diseases NHS Trust, Department of Rheumatology, Bath, United Kingdom

  • University of Bath, Pharmacy and Pharmacology, Bath, United Kingdom

  • University Hospital La Paz, Madrid, Spain

  • Adelphi Real World, Adelphi Real World, Macclesfield, United Kingdom

  • Eli Lilly and Company, Eli Lilly and Company, Indianapolis, IN

  • Università degli Studi del Molise, Academic Rheumatology Unit, Dipartimento di Medicina e Scienze della Salute “Vincenzo Tiberio”, Campobasso, Italy

Locations

  • United Kingdom

  • Spain

  • United States

  • Italy

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

  • Musculoskeletal

  • Dermatology

Disease

  • Psoriatic arthritis

  • Psoriasis

Biomarkers

  • Nutritional risk screening

Drug/Treatment

  • LY2439821

Outcome

  • N/A

Study Design

  • Observational

  • Cross-Sectional

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • Abbvie

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved